Digestive system, diabetes and metabolism

Digestive diseases and diabetes are socially significant diseases along with cardiovascular diseases and cancer. Over 8% of the Bulgarian population is diagnosed with diabetes, and nearly 20% suffers from diseases of the digestive system, and 17% of them are suffering from an ulcer. Despite modern drugs, diagnostics and state-of-the-art therapies, diabetes and digestive diseases very often remain chronic.

Product range

More information about our products is available by clicking on the names below.
Brand Name Generic Name
Linagliptin/Metformin Tchaikapharma Linagliptin/Metformin
Diab PR Gliclazide
Metlinka Sitagliptin/Metformin hydrochloride
Pizona Combi Pioglitazone/Metformin hydrochloride
Aroba Acarbose
Esomeprazole-Tchaikapharma Esomeprazole
Pizona Pioglitazone
LanzAcid Lansoprazole
Diab MR Gliclazide
Pantoprazole-Tchaikapharma Pantoprazole
Metformin-Tchaikapharma Metformin hydrochloridе
Diab Gliclazide